Form D Explorer
Pacific Diabetes Technologies, Inc. · CIK 1835476

Report a data issueCitable research briefCompare issuerPrivate research collection

Pacific Diabetes Technologies, Inc.

CIK 1835476 · Corporation · Inc. DELAWARE · PORTLAND, Oregon · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filing history at a glance

The reported offering amount was $3,000,000 in the Oct 20, 2025 filing and $3,500,000 in the Nov 17, 2025 filing. The two records may concern different offerings. From Mar 14, 2025 to Nov 17, 2025, the explorer stores 2 original notices and 1 amendments.

Filings
3
Original notices
2
Amendments
1
Activity
Mar 14, 2025
through Nov 17, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldOct 20, 2025 · DNov 17, 2025 · D/ALater minus earlier
Reported offering amount$3,000,000$3,500,000$500,000
Reported amount sold$2,920,000$3,385,000$465,000
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001835476-25-000003 · Later SEC source: 0001835476-25-000004

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Nov 17, 2025

Reported offering amount
$3,500,000
Reported exemptions
Rule 506(b)
Reported amount sold
$3,385,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (3)